🇺🇸 FDA
Patent

US 7632510

Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence

granted A61KA61K2039/53A61K2039/70

Quick answer

US patent 7632510 (Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence) held by The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represtented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention
Grant date
Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/53, A61K2039/70, A61K39/12, A61K48/00